Browsing Tag
PDS0101
2 posts
PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones
PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors.
PDS Biotechnology gets FDA fast track status for PDS0101
PDS Biotechnology has secured fast track designation to its PDS0101 in combination with Merck’s KEYTRUDA (pembrolizumab) from the…